US20150011772A1 - Method for producing substituted anthranilic acid derivatives - Google Patents

Method for producing substituted anthranilic acid derivatives Download PDF

Info

Publication number
US20150011772A1
US20150011772A1 US14/375,496 US201314375496A US2015011772A1 US 20150011772 A1 US20150011772 A1 US 20150011772A1 US 201314375496 A US201314375496 A US 201314375496A US 2015011772 A1 US2015011772 A1 US 2015011772A1
Authority
US
United States
Prior art keywords
chlorine
alkyl
fluorine
formula
identically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/375,496
Other languages
English (en)
Inventor
Thomas Himmler
Sergii Pazenok
Frank Volz
Norbert Lui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Bayer Intellectual Property GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Intellectual Property GmbH filed Critical Bayer Intellectual Property GmbH
Assigned to BAYER INTELLECTUAL PROPERTY GMBH reassignment BAYER INTELLECTUAL PROPERTY GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VOLZ, FRANK, LUI, NORBERT, HIMMLER, THOMAS, PAZENOK, SERGII
Publication of US20150011772A1 publication Critical patent/US20150011772A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated

Definitions

  • the present invention relates to a novel process for preparing substituted anthranilic acid derivatives of the formula (I)
  • R 1 , R 3 and R 4 radicals are each as defined above and
  • R 6 and R 7 are each as defined above.
  • substituted anthranilic acid derivatives of the formula (I) require the availability of the corresponding substituted anthranilic acid derivatives of the general formula (VII).
  • substituted anthranilic acid derivatives of the general formula (VII) are either known or can be prepared by known organic chemistry methods. Some of these substituted anthranilic acid derivatives of the general formula (VII), however, can be prepared only in a complex manner, in multiple stages and at high cost, which can lead to uneconomically high costs for the end products as a result of unavoidable yield losses.
  • Substituted anthranilic acid derivatives of the formula (I) are of high interest as compounds having known insecticidal efficacy (see, for example, Bioorg. & Med. Chem. Lett. 15 (2005) 4898-4906; Biorg. & Med. Chem. 16 (2008) 3163-3170). Further, it is already known, that substituted anthranilic acid derivatives of the general formula (VII) can be obtained by reacting substituted anthranilic acid derivatives of the general formula (IX) with carbon monoxide in the presence of a palladium catalyst, of a ligand, of a primary amine and a base (WO 2012/103436). However, it is not known whether anthranilic acid amides of the general formula (IV) can be used correspondingly.
  • R 6 and R 7 are each as defined above to give the substituted anthranilic acid derivatives of the general formula (I).
  • the present invention likewise provides novel compounds of the general formula (IV)
  • R 1 , R 3 , R 4 and X radicals are each as defined above.
  • Alkyl groups substituted by one or more fluorine or chlorine atoms are selected, for example, from trifluoromethyl (CF 3 ), difluoromethyl (CHF 2 ), CCl 3 , CFCl 2 , CF 3 CH 2 , ClCH 2 , CF 3 CCl 2 .
  • Alkyl groups in the context of the present invention are linear or branched hydrocarbyl groups.
  • alkyl and C 1 -C 12 -alkyl encompasses, for example, the meanings of methyl, ethyl, n-, isopropyl, n, iso-, sec- and t-butyl, n-pentyl, n-hexyl, 1,3-dimethylbutyl, 3,3-dimethylbutyl, n-heptyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl.
  • Aryl radicals in the context of the present invention are aromatic hydrocarbyl radicals which may have one, two or more heteroatoms selected from O, N, P and S and may optionally be substituted by further groups.
  • Alkylaryl groups (alkaryl groups) and alkylaryloxy groups in the context of the present invention are, respectively, aryl groups and aryloxy groups which are substituted by alkyl groups, may have a C 1-8 -alkylene chain and may have, in the aryl skeleton or aryloxy skeleton, one or more heteroatoms selected from O, N, P and S.
  • Anthranilic acid derivatives of the formula (IV) can be prepared as follows:
  • the reaction time may, according to the batch size and the temperature, be selected within a range between 1 hour and several hours.
  • Process step 1 can optionally be performed in the presence of a catalyst.
  • a catalyst examples include 4-dimethylaminopyridine or 1-hydroxybenzotriazole.
  • the amount of palladium catalyst used in the process according to the invention is 0.001 to 20 mole percent, based on substituted anthranilic acid derivative of the general formula (IV) used. Preferably 0.005 to 10 mole percent is used, more preferably 0.01 to 5 mole percent.
  • phosphine ligands include chelating bisphosphines. Examples of these include 1,2-bis(diphenylphosphino)ethane, 1,2-bis(diphenylphosphino)propane, 1,2-bis(diphenylphosphino)butane, 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl and 1,1′-bis(diphenylpho sphino)ferrocene.
  • Preferred phosphine ligands are trialkylphosphines such as tri-tert-butylphosphine and triadamantylphosphine, and also triarylphosphines such as triphenylphosphine, tri(ortho-tolyl)phosphine or tri(para-methoxyphenyl)phosphine. Particular preference is given to triphenylphosphine.
  • phosphine 1-20 molar equivalents of phosphine are used, based on the amount of palladium used. Preferably 2-15 molar equivalents are used.
  • Process step 2 of the process according to the invention is performed in the presence of carbon monoxide (CO).
  • CO carbon monoxide
  • the carbon monoxide is typically introduced in gaseous form, and so the reaction is usually performed in an autoclave. It is customary to work at CO pressure 0.1 to 50 bar, preferably at 1 to 25 bar.
  • carbon monoxide in the form of suitable metal carbonyl complexes, for example dicobalt octacarbonyl or molybdenum hexacarbonyl. Preference is given to working with gaseous carbon monoxide.
  • Process step 2 is generally performed in the presence of a base.
  • Suitable bases are organic bases such as trialkylamines, alkylpyridines, phosphazenes and 1,8-diazabicyclo[5.4.0]undecene (DBU).
  • organic bases such as triethylamine, tripropylamine, tributylamine, diisopropylethylamine, pyridine, alkylpyridines, for example 2,6-dimethylpyridine, 2-methyl-5-ethylpyridine or 2,3-dimethylpyridine.
  • the compounds of the general formula (V) or (VI) required for preparation of the substituted anthranilic acid derivatives of the general formula (I) are typically used in an excess, based on the substituted anthranilic acid derivative of the general formula (IV). It is also possible to use the compounds of the general formula (V) or (VI) in such an amount that they simultaneously serve as solvents.
  • the autoclave After closure, the autoclave is purged with carbon monoxide and heated to 110° C., and a carbon monoxide pressure of 10 bar is maintained After 18 hours, the mixture is allowed to cool to room temperature, the autoclave is depressurized, the reaction mixture is stirred with methylene chloride and filtered through kieselguhr, and the filtrate is washed, first with dilute hydrochloric acid and then with water, dried over sodium sulphate and concentrated under reduced pressure. This gives 1.14 g of the title compound.
  • the reaction mixture is stirred at room temperature for one hour and at 40° C. for 1 hour and cooled to room temperature, water and methylene chloride are added thereto, and the organic phase is removed, washed with dilute hydrochloric acid, dried and concentrated.
  • the crude product thus obtained is purified by chromatography on silica gel (cyclohexane/ethyl acetate). This gives 1.30 g of the title compound as a pale beige solid.
  • the autoclave After closure, the autoclave is purged with carbon monoxide and heated to 110° C., and a carbon monoxide pressure of 10 bar is maintained. After 18 hours, the mixture is allowed to cool to room temperature, the autoclave is depressurized, the reaction mixture is stirred with methylene chloride and filtered through kieselguhr, and the filtrate is washed, first with dilute hydrochloric acid and then with water, dried over sodium sulphate and concentrated under reduced pressure. This gives 0.49 g of the title compound.
  • the autoclave After closure, the autoclave is purged with carbon monoxide and heated to 110° C., and a carbon monoxide pressure of 10 bar is maintained. After 18 hours, the mixture is allowed to cool to room temperature, the autoclave is depressurized, the reaction mixture is stirred with methylene chloride and filtered through kieselguhr, and the filtrate is washed, first with dilute hydrochloric acid and then with water, dried over sodium sulphate and concentrated under reduced pressure. This gives 0.475 g of the title compound.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
US14/375,496 2012-02-07 2013-02-06 Method for producing substituted anthranilic acid derivatives Abandoned US20150011772A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12154290.6 2012-02-07
EP12154290 2012-02-07
PCT/EP2013/052350 WO2013117601A1 (de) 2012-02-07 2013-02-06 Verfahren zur herstellung von substituierten anthranilsäure-derivaten

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/052350 A-371-Of-International WO2013117601A1 (de) 2012-02-07 2013-02-06 Verfahren zur herstellung von substituierten anthranilsäure-derivaten

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/924,889 Continuation US9670182B2 (en) 2012-02-07 2015-10-28 Method for producing substituted anthranilic acid derivatives

Publications (1)

Publication Number Publication Date
US20150011772A1 true US20150011772A1 (en) 2015-01-08

Family

ID=47722253

Family Applications (3)

Application Number Title Priority Date Filing Date
US14/375,496 Abandoned US20150011772A1 (en) 2012-02-07 2013-02-06 Method for producing substituted anthranilic acid derivatives
US14/924,889 Active US9670182B2 (en) 2012-02-07 2015-10-28 Method for producing substituted anthranilic acid derivatives
US15/493,087 Expired - Fee Related US9969717B2 (en) 2012-02-07 2017-04-20 Method for producing substituted anthranilic acid derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
US14/924,889 Active US9670182B2 (en) 2012-02-07 2015-10-28 Method for producing substituted anthranilic acid derivatives
US15/493,087 Expired - Fee Related US9969717B2 (en) 2012-02-07 2017-04-20 Method for producing substituted anthranilic acid derivatives

Country Status (10)

Country Link
US (3) US20150011772A1 (ja)
EP (1) EP2812310A1 (ja)
JP (2) JP2015511229A (ja)
KR (1) KR102032979B1 (ja)
CN (2) CN109970707A (ja)
BR (1) BR112014019487A2 (ja)
IL (1) IL233945A0 (ja)
MX (1) MX363730B (ja)
TW (1) TWI644888B (ja)
WO (1) WO2013117601A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI644888B (zh) * 2012-02-07 2018-12-21 拜耳智慧財產有限公司 用於製備經取代之鄰胺苯甲酸衍生物之方法
WO2015162260A1 (en) * 2014-04-25 2015-10-29 Basf Se Process for preparing anthranilamide esters and derivatives
CN104961644B (zh) * 2015-05-20 2017-04-12 上海交通大学 一种制备n‑芳基酰胺化合物的方法
CN106045870B (zh) * 2016-07-07 2018-07-03 上海应用技术学院 一种制备酰胺的方法
CN109180518B (zh) * 2018-10-18 2021-05-18 陕西科技大学 一种仲/叔酰胺类化合物及其合成方法
MX2023003173A (es) 2020-09-17 2023-04-12 Pi Industries Ltd Un proceso para la sintesis de compuestos antranilicos de acido/amida e intermedios de los mismos.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635657B1 (en) * 1998-12-23 2003-10-21 Eli Lilly And Company Aromatic amides
US7456169B2 (en) * 2003-02-27 2008-11-25 Abbott Laboratories Inc. Heterocyclic kinase inhibitors
US7491718B2 (en) * 2002-10-08 2009-02-17 Abbott Laboratories Sulfonamides having antiangiogenic and anticancer activity

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3161456D1 (en) * 1980-02-06 1983-12-29 Hoffmann La Roche Process for the preparation of anthranilic acid derivatives
US5739330A (en) * 1996-02-05 1998-04-14 Hoechst Celanese Corporation Process for preparing quinazolones
US6632815B2 (en) * 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
US6888004B2 (en) * 2001-01-26 2005-05-03 Bristol-Myers Squibb Company Imidazolyl derivatives as corticotropin releasing factor inhibitors
AR036872A1 (es) 2001-08-13 2004-10-13 Du Pont Compuesto de antranilamida, composicion que lo comprende y metodo para controlar una plaga de invertebrados
JP2004004374A (ja) 2002-05-31 2004-01-08 Canon Inc 閃光撮影装置
BR0311707A (pt) * 2002-06-13 2005-03-15 Du Pont Composto, composição e método de controle de pelo menos uma praga invertebrada
JP2004043474A (ja) * 2002-07-05 2004-02-12 Nippon Nohyaku Co Ltd 2−アミノ安息香酸誘導体及びその製造方法
US20040068012A1 (en) * 2002-10-08 2004-04-08 Comess Kenneth M. Sulfonamides having antiangiogenic and anticancer activity
PL209772B1 (pl) 2003-01-28 2011-10-31 Du Pont Antraniloamidy, środek do zwalczania szkodnika będącego bezkręgowcem i sposób zwalczania szkodnika będącego bezkręgowcem
TWI363756B (en) 2004-12-07 2012-05-11 Du Pont Method for preparing n-phenylpyrazole-1-carboxamides
DE102006032168A1 (de) * 2006-06-13 2007-12-20 Bayer Cropscience Ag Anthranilsäurediamid-Derivate mit heteroaromatischen Substituenten
UA99257C2 (ru) * 2006-07-19 2012-08-10 Е.І. Дю Пон Де Немур Енд Компані Способ получения 3-замещенных 2-амино-5-галогенбензамидов
TWI395728B (zh) 2006-12-06 2013-05-11 Du Pont 製備2-胺基-5-氰基苯甲酸衍生物之方法
TWI415827B (zh) 2006-12-21 2013-11-21 Du Pont 製備2-胺基-5-氰基苯甲酸衍生物之方法
TWI430980B (zh) 2007-06-29 2014-03-21 Du Pont 製備2-胺基-5-氰基苯甲酸衍生物之方法
ATE538085T1 (de) 2007-11-08 2012-01-15 Du Pont Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten
TWI432421B (zh) 2007-12-19 2014-04-01 Du Pont 製備2-胺基-5-氰基苯甲酸衍生物之方法
TWI431000B (zh) 2008-03-05 2014-03-21 Du Pont 製備2-胺基-5-氰基苯甲酸衍生物之方法
KR20160148046A (ko) * 2008-12-18 2016-12-23 바이엘 인텔렉쳐 프로퍼티 게엠베하 살해충제로서의 테트라졸 치환된 안트라닐산 아미드
EP2533641B1 (de) * 2010-02-09 2016-07-13 Bayer CropScience AG Hydrazin-substituierte anthranilsäurederivate
KR20130088127A (ko) * 2010-06-15 2013-08-07 바이엘 인텔렉쳐 프로퍼티 게엠베하 신규 오르토-치환된 아릴 아미드 유도체
MX347841B (es) 2010-06-15 2017-05-16 Bayer Ip Gmbh Procedimiento para preparar derivados de antranilamida sustituidos con tetrazoles y polimorfos cristalinos novedosos de estos derivados.
EP2582695B1 (de) * 2010-06-15 2015-09-30 Bayer Intellectual Property GmbH Anthranilsäurediamid-derivate mit zyklischen seitenketten
EP2668153B1 (en) 2011-01-28 2015-03-04 E.I. Du Pont De Nemours And Company Method for preparing 2-aminobenzamide derivatives
TWI644888B (zh) * 2012-02-07 2018-12-21 拜耳智慧財產有限公司 用於製備經取代之鄰胺苯甲酸衍生物之方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635657B1 (en) * 1998-12-23 2003-10-21 Eli Lilly And Company Aromatic amides
US7491718B2 (en) * 2002-10-08 2009-02-17 Abbott Laboratories Sulfonamides having antiangiogenic and anticancer activity
US7456169B2 (en) * 2003-02-27 2008-11-25 Abbott Laboratories Inc. Heterocyclic kinase inhibitors

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Fulford, e-EROS Encyclopedia of Reagents for Organic Synthesis (2001), John Wiley &Sons, Chichester, UK) CODEN:69KUHI *
Seo et al. J. Org. Chem. 2006, 71, 8891-8900 *
Sorgi et al. Encyclopedia of Reagents for Organic Synthesis, 2001, doi:10.1002/047084289X.rt164. *
Valentine et al. Journal of Organic Chemistry, 1981, 46, 4614-4617. *

Also Published As

Publication number Publication date
CN104245666B (zh) 2019-01-11
JP2015511229A (ja) 2015-04-16
MX363730B (es) 2019-04-01
MX2014009317A (es) 2014-11-12
KR20140124810A (ko) 2014-10-27
CN104245666A (zh) 2014-12-24
US9670182B2 (en) 2017-06-06
IL233945A0 (en) 2014-09-30
BR112014019487A2 (pt) 2020-10-27
US20170217934A1 (en) 2017-08-03
JP6438551B2 (ja) 2018-12-12
WO2013117601A1 (de) 2013-08-15
US9969717B2 (en) 2018-05-15
TWI644888B (zh) 2018-12-21
JP2018027964A (ja) 2018-02-22
EP2812310A1 (de) 2014-12-17
TW201336811A (zh) 2013-09-16
KR102032979B1 (ko) 2019-10-16
CN109970707A (zh) 2019-07-05
US20160046607A1 (en) 2016-02-18

Similar Documents

Publication Publication Date Title
US9969717B2 (en) Method for producing substituted anthranilic acid derivatives
US20110003999A1 (en) Process for Preparing Substituted Biphenylanilides
JP5970065B2 (ja) ピラゾール酸をアントラニル酸エステルと反応させる工程によってテトラゾール置換アントラニル酸ジアミド誘導体を製造する方法
KR101949551B1 (ko) 벤족사지논을 아민과 반응시켜 테트라졸-치환된 안트라닐산 디아미드 유도체를 제조하는 방법
KR102167814B1 (ko) 카복사미드 제조 방법
KR101652360B1 (ko) 치환된 비페닐아닐라이드의 제조방법
JP5140776B1 (ja) 1−置換−3−フルオロアルキルピラゾール−4−カルボン酸エステルの製造方法
US9458091B2 (en) Aromatic amidecarboxylic acid and process for producing the same
KR20160141788A (ko) N-[3-(벤질카바모일)페닐]-1h-피라졸-5-카복사미드의 제조방법
PL189843B1 (pl) Sposób wytwarzania aryloamidów heteroaromatycznych kwasów karboksylowych
US9481650B2 (en) Process for the preparation of 2-trifluoromethyl isonicotinic acid and esters

Legal Events

Date Code Title Description
AS Assignment

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HIMMLER, THOMAS;PAZENOK, SERGII;VOLZ, FRANK;AND OTHERS;SIGNING DATES FROM 20140721 TO 20140725;REEL/FRAME:033476/0149

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION